JDD Corner

JDD November 2022 Issue Highlights | Lasers, Light Sources, and Devices

The November issue of the Journal of Drugs in Dermatology (JDD) focuses on lasers, lights sources, and devices featuring original articles and case reports exploring topics such as combination of platelet rich plasma and 1550 nm fractional laser for androgenetic alopecia, safety of combination laser procedures in single clinic visit, efficacy of a fractionated 1540 …

Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient

Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, …

JDD September Issue Highlights | Special Focus: Aesthetic Treatments

The September issue of the Journal of Drugs in Dermatology (JDD) focuses on aesthetic treatments and features original articles exploring topics such as reconstruction of the glabella and nasal root, perioral rejuvenation with high molecular weight HA and amino acid treatment, blue light and skin health, and many more.  Check out this month’s issue highlights straight …

JDD August Issue Highlights | Special Focus: Psoriasis

The August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen …

JDD July Issue Highlights | Skin of Color Issue

The July issue of the Journal of Drugs in Dermatology (JDD) focuses on skin of color topics with the perfect mix of original articles, case reports, brief communications, and letters to the editor. Among many of the topics explored in this issue are skin of color dermatology on TikTok, disparities in melanoma recognition in skin …

PRP for Scarring Alopecia Due to Discoid Lupus Erythematosus (DLE)

JDD authors Hannah Polster MD, Karen Kagha MD, and  Janiene Luke MD report a case of platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus. Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient’s blood containing platelets up to 7 times higher than normal plasma.1 Originally indicated …

JDD Issue Highlights | June 2022: Acne & Rosacea

The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on …

Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab

INTRODUCTION Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and sarcoidosis.1 With concurrent facial palsy and a plicated tongue, the condition is referred to as Melkersson-Rosenthal syndrome.1,2 Both CG and Melkersson-Rosenthal syndrome are in the orofacial granulomatosis family …

JDD Issue Highlights | May 2022

The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk: Insights in Skin of Color Patients With Atopic Dermatitis and …

An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology

INTRODUCTION As the United States population becomes increasingly diverse, it is exceedingly important for dermatologists to be knowledgeable about treating patients with skin of color (SOC). The published literature is an especially valuable resource for treating SOC. Many prevalent dermatological conditions, such as acne vulgaris, atopic dermatitis, and psoriasis, differ histologically and/or clinically in SOC, …